Skip to main content

Dr. Mark W. Walberg, M.D.

Medical Oncology (Medical Oncology Physician)

  • Medicare participating

At a glance

In the NPI registry since
2006
Medicare patients seen, 2024
421

Licensed in Texas since 1994, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    TX license J6272 (first issued 1994; voluntary charity care only)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Medicare patients and services

Medicare patients, 2024
421
Services billed
72,795
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, pembrolizumab, 1 mg13,40049
Injection, fosaprepitant, 1 mg12,00056
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)7,14012
Injection, paclitaxel, 1 mg6,51731
Injection, nivolumab, 1 mg5,94011
Injection, iron sucrose, 1 mg5,70022
Injection, oxaliplatin, 0.5 mg4,40011
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml4,20943
Injection, daratumumab, 10 mg and hyaluronidase-fihj3,60014
Injection, dexamethasone sodium phosphate, 1 mg1,862113

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Hydrocodone-Acetaminophen (hydrocodone/acetaminophen)
Other prescribers in Dallas, TX
36
Lenvima (lenvatinib mesylate)16
Prochlorperazine Maleate
Other prescribers in Dallas, TX
16
Prednisone
Other prescribers in Dallas, TX
12
Sorafenib (sorafenib tosylate)11

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 3 payments worth $94.33 in total to this clinician.

By company
Janssen Scientific Affairs, LLC$50.80
Legend Biotech USA Inc.$27.93
AbbVie Inc.$15.60
By type
Food and Beverage$94.33

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Other Medical Oncology clinicians in Dallas

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 26, 2011), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1306884333. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.